advertisement
Katsanos A 33
Showing records 1 to 25 | Display all abstracts from Katsanos A79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Konstas AG
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
79188 Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment
Konstas AG
Advances in Therapy 2018; 35: 1775-1804
78989 The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results
Quaranta L
Journal of Glaucoma 2018; 27: 856-863
79188 Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment
Kahook MY
Advances in Therapy 2018; 35: 1775-1804
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Katsanos A
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78989 The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results
Biagioli E
Journal of Glaucoma 2018; 27: 856-863
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Athanasopoulos GP
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78989 The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results
Riva I
Journal of Glaucoma 2018; 27: 856-863
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Athanasopoulos GP
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
79188 Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment
Araie M
Advances in Therapy 2018; 35: 1775-1804
78989 The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results
Galli F
Journal of Glaucoma 2018; 27: 856-863
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Voudouragkaki IC
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
79188 Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment
Katsanos A
Advances in Therapy 2018; 35: 1775-1804
78989 The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results
Poli D
Journal of Glaucoma 2018; 27: 856-863
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Panagiotou ES
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
79188 Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment
Quaranta L; Rossetti L
Advances in Therapy 2018; 35: 1775-1804
78989 The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results
Rulli E
Journal of Glaucoma 2018; 27: 856-863
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Pagkalidou E; Haidich AB
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
78989 The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results
Katsanos A
Journal of Glaucoma 2018; 27: 856-863
79188 Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment
Holló G
Advances in Therapy 2018; 35: 1775-1804
78989 The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results
Longo A
Journal of Glaucoma 2018; 27: 856-863
79188 Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment
Detorakis ET
Advances in Therapy 2018; 35: 1775-1804
79208 Preservative-free tafluprost/timolol fixed combination: comparative 24-h efficacy administered morning or evening in open-angle glaucoma patients
Giannoulis DA
Expert Opinion in Pharmacotherapy 2018; 0: 1-8
79188 Diurnal and 24-h Intraocular Pressures in Glaucoma: Monitoring Strategies and Impact on Prognosis and Treatment
Oddone F
Advances in Therapy 2018; 35: 1775-1804
78989 The Glaucoma Italian Pediatric Study (GIPSy): 3-Year Results
Uva MG
Journal of Glaucoma 2018; 27: 856-863